choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • SARS & Vaccination

SARS & Vaccination Newsletter
  • mRNA COVID vaccine during cancer therapy linked to 2x survival rate 24 Oct 2025 07:08 GMT

    … : mRNA-based COVID vaccines. “This study demonstrates … checkpoint inhibitors, these vaccines produce powerful antitumor immune … vaccines like those developed by Pfizer and Moderna for SARS … tumors. They compared vaccinated and unvaccinated patients, …

  • How COVID mRNA vaccines may make cancer treatments more effective 24 Oct 2025 01:20 GMT

    … study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint … -ready targets. Study: SARS-CoV-2 mRNA vaccines sensitize tumours to immune … , researchers investigated whether SARS-CoV-2 mRNA vaccines could sensitize cancerous tumors …

  • RSV Vaccine 92% Effective Against Severe Outcomes in Adults Aged 60 and Older 23 Oct 2025 23:14 GMT

    … effectiveness of the RSV vaccine against “respiratory illness and … .6% of controls.” The vaccine effectiveness (VE) of the … The results indicate that the vaccine “has higher VE against … than other current respiratory vaccines, including SARS-CoV-2, influenza, …

  • Data supports usage of mRNA-1273.815 Covid-19 vaccine in young children 23 Oct 2025 21:48 GMT

    … from a single-dose vaccine regimen currently recommended for … population. However, as SARS-CoV-2 has become … acquired immunity through infection or vaccination. However, infants and … eligibility for Omicron-adapted vaccines to include younger children …

  • <![CDATA[Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines]]> 23 Oct 2025 19:34 GMT

    … COVID symptoms.” Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection, also known … clinicians taking concerns about unexpected vaccine responses seriously,” the study authors … Aly Z. Postacute Sequelae of SARS-CoV-2 Infection in the …

  • COVID Vaccines May Boost Cancer Immunotherapy 23 Oct 2025 19:47 GMT

    … with immune checkpoint inhibitors, these vaccines produce powerful antitumor immune responses … COVID vaccines contain synthetic molecules that encode blueprints for making the SARS … the links between mRNA SARS-CoV-2 vaccines, immune activation and outcomes …

  • COVID-19, mRNA vaccines may help cancer treatments work better: Study 23 Oct 2025 19:22 GMT

    … mRNA vaccines, originally designed to protect against SARS-CoV- … response triggered by the vaccines may “sensitize” tumors … SARS-CoV-2 mRNA vaccines can change that. “mRNA vaccines targeting SARS … experiments with mice, the vaccines triggered a powerful wave …

  • Study finds mRNA coronavirus vaccines prolonged life of cancer patients 23 Oct 2025 13:36 GMT

    … survival when they were vaccinated. The immunotherapy – called … SARS-CoV-2, researchers were able to design an mRNA vaccine … the control vaccines. Although the control vaccines were completely … . Making personalized cancer vaccines would require conducting a …

  • South Korea study isn’t evidence that COVID-19 vaccines cause cancer 23 Oct 2025 08:47 GMT

    … conclusions. The majority of vaccinated people received the Pfizer- … carcinogenic effect from the vaccines.” This bias arises because … a COVID-19 mRNA vaccine. These vaccines work by providing … was exposed to SARS-CoV-2, regardless of vaccination status. If …

  • SARS-CoV-2 mRNA Vaccines Boost Tumor Immunotherapy 23 Oct 2025 07:49 GMT

    … mechanism by which SARS-CoV-2 mRNA vaccines can sensitize tumours … effect of SARS-CoV-2 spike mRNA vaccines administered as … Research: Use of SARS-CoV-2 mRNA vaccines to sensitize tumours … therapy. Article Title: SARS-CoV-2 mRNA vaccines sensitize tumours to …

Satisfied with the content?

Continue to create your account.